MicroRNA-155 and microRNA-21 promote the expansion of functional myeloid-derived suppressor cells

Journal of Immunology

Volumn 192, Issue 3, 2014, Pages 1034-1043

  Li, Limin ^a   Zhang, Jing ^a   Diao, Wenli ^a   Wang, Dong ^a   Wei, Yao ^a   Zhang, Chen Yu ^a   Zen, Ke ^a  

^a NANJING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 6; MICRORNA 155; MICRORNA 21; PHOSPHATASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN SHIP1; STAT3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; BONE MARROW; CELL EXPANSION; CELL FUNCTION; CONTROLLED STUDY; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GRANULOCYTE; GRANULOCYTIC MYELOID DERIVED SUPPRESSOR CELL; MALE; MONOCYTE; MONOCYTIC MYELOID DERIVED SUPPRESSOR CELL; MOUSE; MYELOID DERIVED SUPPRESSOR CELL; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; SPLEEN; SUPPRESSOR CELL; UPREGULATION;

ANIMALS; BONE MARROW CELLS; CARCINOMA, LEWIS LUNG; CELLS, CULTURED; DEXAMETHASONE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; INTERLEUKIN-6; MALE; MICE; MICE, INBRED C57BL; MICRORNAS; MYELOID CELLS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHOSPHORIC MONOESTER HYDROLASES; PTEN PHOSPHOHYDROLASE; RNA, NEOPLASM; RNA, SMALL INTERFERING; STAT3 TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA1; UP-REGULATION;

EID: 84893357722     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1301309     Document Type: Article

References (53)

1. Gabrilovich, D. 2004. Mechanisms and functional significance of tumourinduced dendritic-cell defects. Nat. Rev. Immunol. 4: 941-952.
2. Gabrilovich, D. I., and S. Nagaraj. 2009. Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 9: 162-174.
3. Filipazzi, P., R. Valenti, V. Huber, L. Pilla, P. Canese, M. Iero, C. Castelli, L. Mariani, G. Parmiani, and L. Rivoltini. 2007. Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor-based antitumor vaccine. J. Clin. Oncol. 25: 2546-2553.
4. Mirza, N., M. Fishman, I. Fricke, M. Dunn, A. M. Neuger, T. J. Frost, R. M. Lush, S. Antonia, and D. I. Gabrilovich. 2006. All-trans-retinoic acid improves differentiation of myeloid cells and immune response in cancer patients. Cancer Res. 66: 9299-9307.
5. Zea, A. H., P. C. Rodriguez, M. B. Atkins, C. Hernandez, S. Signoretti, J. Zabaleta, D. McDermott, D. Quiceno, A. Youmans, A. O'Neill, et al. 2005. Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion. Cancer Res. 65: 3044-3048.
6. Ostrand-Rosenberg, S., and P. Sinha. 2009. Myeloid-derived suppressor cells: linking inflammation and cancer. J. Immunol. 182: 4499-4506.
7. Hestdal, K., F. W. Ruscetti, J. N. Ihle, S. E. Jacobsen, C. M. Dubois, W. C. Kopp, D. L. Longo, and J. R. Keller. 1991. Characterization and regulation of RB6-8C5 antigen expression on murine bone marrow cells. J. Immunol. 147: 22-28.
8. Youn, J. I., S. Nagaraj, M. Collazo, and D. I. Gabrilovich. 2008. Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J. Immunol. 181: 5791-5802.
9. Bronte, V., and P. Zanovello. 2005. Regulation of immune responses by L-Arginine metabolism. Nat. Rev. Immunol. 5: 641-654.
10. Meyer, C., A. Sevko, M. Ramacher, A. V. Bazhin, C. S. Falk, W. Osen, I. Borrello, M. Kato, D. Schadendorf, M. Baniyash, and V. Umansky. 2011. Chronic inflammation promotes myeloid-derived suppressor cell activation blocking antitumor immunity in transgenic mouse melanoma model. Proc. Natl. Acad. Sci. USA 108: 17111-17116.
11. Sinha, P., O. Chornoguz, V. K. Clements, K. A. Artemenko, R. A. Zubarev, and S. Ostrand-Rosenberg. 2011. Myeloid-derived suppressor cells express the death receptor Fas and apoptose in response to T cell-expressed FasL. Blood 117: 5381-5390.
12. Cripps, J. G., and J. D. Gorham. 2011. MDSC in autoimmunity. Int. Immunopharmacol. 11: 789-793.
13. Van Ginderachter, J. A., A. Beschin, P. De Baetselier, and G. Raes. 2010. Myeloid-derived suppressor cells in parasitic infections. Eur. J. Immunol. 40: 2976-2985.
14. Zhang, J., B. Wang, W. Zhang, Y. Wei, Z. Bian, C. Y. Zhang, L. Li, and K. Zen. 2013. Protein tyrosine phosphatase 1B deficiency ameliorates murine experimental colitis via the expansion of myeloid-derived suppressor cells. PLoS One 8: e70828.
15. Nicholson, L. B., B. J. Raveney, and M. Munder. 2009. Monocyte dependent regulation of autoimmune inflammation. Curr. Mol. Med. 9: 23-29.
16. Bartel, D. P. 2004. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
17. Esquela-Kerscher, A., and F. J. Slack. 2006. Oncomirs -microRNAs with a role in cancer. Nat. Rev. Cancer 6: 259-269.
18. Zhang, B., X. Pan, G. P. Cobb, and T. A. Anderson. 2007. microRNAs as oncogenes and tumor suppressors. Dev. Biol. 302: 1-12.
19. Taganov, K. D., M. P. Boldin, and D. Baltimore. 2007. MicroRNAs and immunity: tiny players in a big field. Immunity 26: 133-137.
20. Lodish, H. F., B. Zhou, G. Liu, and C. Z. Chen. 2008. Micromanagement of the immune system by microRNAs. Nat. Rev. Immunol. 8: 120-130.
21. Ponomarev, E. D., T. Veremeyko, N. Barteneva, A. M. Krichevsky, and H. L. Weiner. 2011. MicroRNA-124 promotes microglia quiescence and suppresses EAE by deactivating macrophages via the C/EBP-A-PU.1 pathway. Nat. Med. 17: 64-70.
22. Meng, F., R. Henson, M. Lang, H. Wehbe, S. Maheshwari, J. T. Mendell, J. Jiang, T. D. Schmittgen, and T. Patel. 2006. Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. Gastroenterology 130: 2113-2129.
23. Li, L. M., D. X. Hou, Y. L. Guo, J. W. Yang, Y. Liu, C. Y. Zhang, and K. Zen. 2011. Role of microRNA-214-targeting phosphatase and tensin homolog in advanced glycation end product-induced apoptosis delay in monocytes. J. Immunol. 186: 2552-2560.
24. Calame, K. 2007. MicroRNA-155 function in B cells. Immunity 27: 825-827.
25. Turner, M., and E. Vigorito. 2008. Regulation of B-And T-cell differentiation by a single microRNA. Biochem. Soc. Trans. 36: 531-533.
26. Kurowska-Stolarska, M., S. Alivernini, L. E. Ballantine, D. L. Asquith, N. L. Millar, D. S. Gilchrist, J. Reilly, M. Ierna, A. R. Fraser, B. Stolarski, et al. 2011. MicroRNA-155 as a proinflammatory regulator in clinical and experimental arthritis. Proc. Natl. Acad. Sci. USA 108: 11193-11198.
27. Bhattacharyya, S., N. S. Balakathiresan, C. Dalgard, U. Gutti, D. Armistead, C. Jozwik, M. Srivastava, H. B. Pollard, and R. Biswas. 2011. Elevated miR-155 promotes inflammation in cystic fibrosis by driving hyperexpression of interleukin-8. J. Biol. Chem. 286: 11604-11615.
28. O'Connell, R. M., D. Kahn, W. S. Gibson, J. L. Round, R. L. Scholz, A. A. Chaudhuri, M. E. Kahn, D. S. Rao, and D. Baltimore. 2010. MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development. Immunity 33: 607-619.
29. Sonkoly, E., P. Janson, M. L. Majuri, T. Savinko, N. Fyhrquist, L. Eidsmo, N. Xu, F. Meisgen, T. Wei, M. Bradley, et al. 2010. MiR-155 is overexpressed in patients with atopic dermatitis and modulates T-cell proliferative responses by targeting cytotoxic T lymphocyte-Associated antigen 4. J. Allergy Clin. Immunol. 126: 581-589 e581-520.
30. Bala, S., M. Marcos, K. Kodys, T. Csak, D. Catalano, P. Mandrekar, and G. Szabo. 2011. Up-regulation of microRNA-155 in macrophages contributes to increased tumor necrosis factor a (TNFa) production via increased mRNA halflife in alcoholic liver disease. J. Biol. Chem. 286: 1436-1444.
31. McCoy, C. E., F. J. Sheedy, J. E. Qualls, S. L. Doyle, S. R. Quinn, P. J. Murray, and L. A. O'Neill. 2010. IL-10 inhibits miR-155 induction by Toll-like receptors. J. Biol. Chem. 285: 20492-20498.
32. Marigo, I., E. Bosio, S. Solito, C. Mesa, A. Fernandez, L. Dolcetti, S. Ugel, N. Sonda, S. Bicciato, E. Falisi, et al. 2010. Tumor-induced tolerance and immune suppression depend on the C/EBPb transcription factor. Immunity 32: 790-802.
33. Pilon-Thomas, S., N. Nelson, N. Vohra, M. Jerald, L. Pendleton, K. Szekeres, and T. Ghansah. 2011. Murine pancreatic adenocarcinoma dampens SHIP-1 expression and alters MDSC homeostasis and function. PLoS One 6: e27729.
34. Liu, Y., L. Lai, Q. Chen, Y. Song, S. Xu, F. Ma, X. Wang, J. Wang, H. Yu, X. Cao, and Q. Wang. 2012. MicroRNA-494 is required for the accumulation and functions of tumor-expanded myeloid-derived suppressor cells via targeting of PTEN. J. Immunol. 188: 5500-5510.
35. Kujawski, M., M. Kortylewski, H. Lee, A. Herrmann, H. Kay, and H. Yu. 2008. Stat3 mediates myeloid cell-dependent tumor angiogenesis in mice. J. Clin. Invest. 118: 3367-3377.
36. Ehrchen, J., L. Steinmuller, K. Barczyk, K. Tenbrock, W. Nacken, M. Eisenacher, U. Nordhues, C. Sorg, C. Sunderko tter, and J. Roth. 2007. Glucocorticoids induce differentiation of a specifically activated, anti-inflammatory subtype of human monocytes. Blood 109: 1265-1274.
37. Rhen, T., and J. A. Cidlowski. 2005. Antiinflammatory action of glucocorticoids -new mechanisms for old drugs. N. Engl. J. Med. 353: 1711-1723.
38. Varga, G., J. Ehrchen, A. Tsianakas, K. Tenbrock, A. Rattenholl, S. Seeliger, M. Mack, J. Roth, and C. Sunderkoetter. 2008. Glucocorticoids induce an activated, anti-inflammatory monocyte subset in mice that resembles myeloidderived suppressor cells. J. Leukoc. Biol. 84: 644-650.
39. Chen, C. Z., L. Li, H. F. Lodish, and D. P. Bartel. 2004. MicroRNAs modulate hematopoietic lineage differentiation. Science 303: 83-86.
40. Baltimore, D., M. P. Boldin, R. M. O'Connell, D. S. Rao, and K. D. Taganov. 2008. MicroRNAs: new regulators of immune cell development and function. Nat. Immunol. 9: 839-845.
41. Pedersen, I. M., G. Cheng, S.Wieland, S. Volinia, C. M. Croce, F. V. Chisari, and M. David. 2007. Interferon modulation of cellular microRNAs as an antiviral mechanism. Nature 449: 919-922.
42. Liu, Q. F., M. M. Zhang, X. R. Jiang, Z. Q. Zhang, L. Y. Dai, S. P. Min, X. L. Wu, Q. S. He, J. Y. Liu, Y. Zhang, et al. 2011. miR-223 suppresses differentiation of tumor-induced CD11b+Gr1+ myeloid-derived suppressor cells from bone marrow cells. Int. J. Cancer 129: 2662-2673.
43. Zhang, M. M., Q. F. Liu, S. P. Mi, X. Liang, Z. Q. Zhang, X. M. Su, J. Y. Liu, Y. Y. Chen, M. M. Wang, Y. A. Zhang, et al. 2011. Both miR-17-5p and miR-20a alleviate suppressive potential of myeloid-derived suppressor cells by modulating STAT3 expression. J. Immunol. 186: 4716-4724.
44. Yang, M. M., H. C. Shen, C. Qiu, Y. Ni, L. G. Wang, W. Dong, Y. D. Liao, and J. J. Du. 2013. High expression of miR-21 and miR-155 predicts recurrence and unfavourable survival in non-small cell lung cancer. Eur. J. Cancer 49: 604-615.
45. Kortylewski, M., M. Kujawski, T. Wang, S. Wei, S. Zhang, S. Pilon-Thomas, G. Niu, H. Kay, J. Mulé, W. G. Kerr, et al. 2005. Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity. Nat. Med. 11: 1314-1321.
46. Ware, M. D., P. Rosten, J. E. Damen, L. Liu, R. K. Humphries, and G. Krystal. 1996. Cloning and characterization of human SHIP, the 145-kD inositol 5-phosphatase that associates with SHC after cytokine stimulation. Blood 88: 2833-2840.
47. van Dijk, T. B., E. van Den Akker, M. P. Amelsvoort, H. Mano, B. Lowenberg, and M. von Lindern. 2000. Stem cell factor induces phosphatidylinositol 39-kinase-dependent Lyn/Tec/Dok-1 complex formation in hematopoietic cells. Blood 96: 3406-3413.
48. Chu, E. C., and A. S. Tarnawski. 2004. PTEN regulatory functions in tumor suppression and cell biology. Med. Sci. Monit. 10: RA235-RA241.
49. Lee, D. W., M. Futami, M. Carroll, Y. Feng, Z. Wang, M. Fernandez, Z. Whichard, Y. Chen, S. Kornblau, E. J. Shpall, et al. 2012. Loss of SHIP-1 protein expression in high-risk myelodysplastic syndromes is associated with miR-210 and miR-155. Oncogene 31: 4085-4094.
50. Chalmin, F., S. Ladoire, G. Mignot, J. Vincent, M. Bruchard, J. P. Remy-Martin, W. Boireau, A. Rouleau, B. Simon, D. Lanneau, et al. 2010. Membraneassociated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells. J. Clin. Invest. 120: 457-471.
51. Cheng, P., C. A. Corzo, N. Luetteke, B. Yu, S. Nagaraj, M. M. Bui, M. Ortiz, W. Nacken, C. Sorg, T. Vogl, et al. 2008. Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein. J. Exp. Med. 205: 2235-2249.
52. Sionov, R. V. 2013. MicroRNAs and glucocorticoid-induced apoptosis in lymphoid malignancies. ISRN Hematol. 2013: 348212.
53. Lu, T. X., J. D. Sherrill, T. Wen, A. J. Plassard, J. A. Besse, J. P. Abonia, J. P. Franciosi, P. E. Putnam, M. Eby, L. J. Martin, et al. 2012. MicroRNA signature in patients with eosinophilic esophagitis, reversibility with glucocorticoids, and assessment as disease biomarkers. J. Allergy Clin. Immunol. 129: 1064-1075 e1069.